ArticleMolecular pharmaceutics2018

Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis.

Xin Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.